Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 4/2019

04.07.2019 | Clinical Investigation

Moraxella species: infectious microbes identified by use of time-of-flight mass spectrometry

verfasst von: Shunsuke Takahashi, Kazuhiro Murata, Kenji Ozawa, Hiroki Yamada, Hideaki Kawakami, Asami Nakayama, Yuko Asano, Kiyofumi Mochizuki, Hiroshige Mikamo

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To report the clinical manifestations, identification, antimicrobial susceptibilities, and treatment outcomes of ocular infections caused by Moraxella species.

Study design

Retrospective study.

Patients and methods

The medical records of all patients treated at the Departments of Ophthalmology of the Ogaki Municipal Hospital and the Gifu University Graduate School of Medicine for ocular infections caused by Moraxella species between January 2011 and June 2017 were examined. The stored Moraxella species isolated from ocular samples were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), molecular identification, and the biochemical properties.

Results

Sixteen eyes of 16 patients were treated for Moraxella ocular infections. The patients’ median age was 72 years. A predisposing systemic or ocular condition was identified in 15 of the patients. Nine of the patients developed keratitis; four, conjunctivitis; and three, blebitis. M lacunata (6 eyes), M catarrhalis (6), M nonliquefaciens (3), and M osloensis (1) were identified by MALDI-TOF MS. All isolates were sensitive to levofloxacin, tobramycin, ceftazidime, ceftriaxone, and cefazolin. Twelve patients with keratitis or blebitis were treated with various topical antimicrobial combinations, and systemic antibiotics were used in 10 of the 12 patients. The mean time for the complete closure of the epithelial defects with keratitis was 24 days. The visual outcomes after treatment were favorable except in 1 keratitis patient who underwent enucleation.

Conclusions

The use of duo-therapy with a combination of fluoroquinolone and cefmenoxime should be considered in cases nonresponsive to monotherapy, such as keratitis and bleb-associated infections. MALDI-TOF MS is useful for the identification of Moraxella to the species level.
Literatur
1.
Zurück zum Zitat Berrocal AM, Scott IU, Miller D, Flynn HW Jr. Endophthalmitis caused by Moraxella species. Am J Ophthalmol. 2001;132:788–90.CrossRefPubMed Berrocal AM, Scott IU, Miller D, Flynn HW Jr. Endophthalmitis caused by Moraxella species. Am J Ophthalmol. 2001;132:788–90.CrossRefPubMed
2.
Zurück zum Zitat Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol. 2001;85:842–7.CrossRefPubMedPubMedCentral Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol. 2001;85:842–7.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Berrocal AM, Scott IU, Miller D, Flynn HW Jr. Endophthalmitis caused by Moraxella osloensis. Graefes Arch Clin Exp Ophthalmol. 2002;240:329–30.CrossRefPubMed Berrocal AM, Scott IU, Miller D, Flynn HW Jr. Endophthalmitis caused by Moraxella osloensis. Graefes Arch Clin Exp Ophthalmol. 2002;240:329–30.CrossRefPubMed
4.
Zurück zum Zitat Das S, Constantinou M, Daniell M, Taylor HR. Moraxella keratitis: predisposing factors and clinical review of 95 cases. Br J Ophthalmol. 2006;90:1236–8.CrossRefPubMedPubMedCentral Das S, Constantinou M, Daniell M, Taylor HR. Moraxella keratitis: predisposing factors and clinical review of 95 cases. Br J Ophthalmol. 2006;90:1236–8.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Inoue H, Suzuki T, Inoue T, Hattori T, Nejima R, Todokoro D, et al. Clinical characteristics and bacteriological profile of Moraxella keratitis. Cornea. 2015;34:110–9.CrossRef Inoue H, Suzuki T, Inoue T, Hattori T, Nejima R, Todokoro D, et al. Clinical characteristics and bacteriological profile of Moraxella keratitis. Cornea. 2015;34:110–9.CrossRef
6.
Zurück zum Zitat Tobimatsu Y, Inada N, Shoji J, Yamagami S. Clinical characteristics of 17 patients with Moraxella keratitis. Semin Ophthalmol. 2018;33:726–32.CrossRefPubMed Tobimatsu Y, Inada N, Shoji J, Yamagami S. Clinical characteristics of 17 patients with Moraxella keratitis. Semin Ophthalmol. 2018;33:726–32.CrossRefPubMed
8.
Zurück zum Zitat Varaprasathan G, Miller K, Lietman T, Whitcher JP, Cevallos V, Okumoto M, et al. Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation. Cornea. 2004;23:360–4.CrossRefPubMed Varaprasathan G, Miller K, Lietman T, Whitcher JP, Cevallos V, Okumoto M, et al. Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation. Cornea. 2004;23:360–4.CrossRefPubMed
9.
Zurück zum Zitat Cornut PL, Chiquet C, Bron A, Romanet JP, Lina G, Lafontaine PO, FRIENDS Group, et al. Microbiologic identification of bleb-related delayed-onset endophthalmitis caused by Moraxella species. J Glaucoma. 2008;7:541–5.CrossRef Cornut PL, Chiquet C, Bron A, Romanet JP, Lina G, Lafontaine PO, FRIENDS Group, et al. Microbiologic identification of bleb-related delayed-onset endophthalmitis caused by Moraxella species. J Glaucoma. 2008;7:541–5.CrossRef
10.
Zurück zum Zitat Jacobs DJ, Leng T, Flynn HW Jr, Shi W, Miller D, Gedde SJ. Delayed-onset bleb-associated endophthalmitis: presentation and outcome by culture result. Clin Ophthalmol. 2011;5:739–44.CrossRefPubMedPubMedCentral Jacobs DJ, Leng T, Flynn HW Jr, Shi W, Miller D, Gedde SJ. Delayed-onset bleb-associated endophthalmitis: presentation and outcome by culture result. Clin Ophthalmol. 2011;5:739–44.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Takahashi H, Fujimura S, Ubukata S, Sato E, Shoji M, Utagawa M, et al. Pneumonia after earthquake, Japan, 2011. Emerg Infect Dis. 2012;18:1909–11.CrossRefPubMedPubMedCentral Takahashi H, Fujimura S, Ubukata S, Sato E, Shoji M, Utagawa M, et al. Pneumonia after earthquake, Japan, 2011. Emerg Infect Dis. 2012;18:1909–11.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Dingle TC, Butler-Wu SM. Maldi-tof mass spectrometry for microorganism identification. Clin Lab Med. 2013;33:589–609.CrossRefPubMed Dingle TC, Butler-Wu SM. Maldi-tof mass spectrometry for microorganism identification. Clin Lab Med. 2013;33:589–609.CrossRefPubMed
13.
14.
Zurück zum Zitat Masaki T, Ohkusu K, Ezaki T, Miyamoto H. Nocardia elegans infection involving purulent arthritis in humans. J Infect Chemother. 2012;18:386–9.CrossRefPubMed Masaki T, Ohkusu K, Ezaki T, Miyamoto H. Nocardia elegans infection involving purulent arthritis in humans. J Infect Chemother. 2012;18:386–9.CrossRefPubMed
15.
Zurück zum Zitat Pettersson B, Kodjo A, Ronaghi M, Uhlén M, Tønjum T. Phylogeny of the family Moraxellaceae by 16S rDNA sequence analysis, with special emphasis on differentiation of Moraxella species. Int J Syst Bacteriol. 1998;48:75–89.CrossRefPubMed Pettersson B, Kodjo A, Ronaghi M, Uhlén M, Tønjum T. Phylogeny of the family Moraxellaceae by 16S rDNA sequence analysis, with special emphasis on differentiation of Moraxella species. Int J Syst Bacteriol. 1998;48:75–89.CrossRefPubMed
16.
Zurück zum Zitat Orlans HO, Hornby SJ, Bowler IC. In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. Eye (Lond). 2011;25:489–93.CrossRef Orlans HO, Hornby SJ, Bowler IC. In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. Eye (Lond). 2011;25:489–93.CrossRef
17.
Zurück zum Zitat National Surveillance of Infectious Keratitis in Japan. National Surveillance of Infectious Keratitis in Japan: current status of isolates, patient background, and treatment. Nippon Ganka Gakkai Zasshi. 2006;110:961–72 (in Japanese). National Surveillance of Infectious Keratitis in Japan. National Surveillance of Infectious Keratitis in Japan: current status of isolates, patient background, and treatment. Nippon Ganka Gakkai Zasshi. 2006;110:961–72 (in Japanese).
18.
Zurück zum Zitat Tan SZ, Walkden A, Au L, Fullwood C, Hamilton A, Qamruddin A, et al. Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital. Eye (Lond). 2017;31:1229–36.CrossRef Tan SZ, Walkden A, Au L, Fullwood C, Hamilton A, Qamruddin A, et al. Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital. Eye (Lond). 2017;31:1229–36.CrossRef
19.
Zurück zum Zitat Mian SI, Malta JB. Moraxella keratitis: risk factors, presentation, and management. Acta Ophthalmol. 2011;89:e208–9.CrossRefPubMed Mian SI, Malta JB. Moraxella keratitis: risk factors, presentation, and management. Acta Ophthalmol. 2011;89:e208–9.CrossRefPubMed
21.
Zurück zum Zitat Morax V. Note sur un diplobacille pathogène pour la conjonctivite humaine. Ann Inst Pasteur. 1896;10:337–45. Morax V. Note sur un diplobacille pathogène pour la conjonctivite humaine. Ann Inst Pasteur. 1896;10:337–45.
22.
Zurück zum Zitat Axenfeld T. Über die chronische Diplobacille conjunctivitis. Zentralbl Bakteriol. 1897;21:1–9. Axenfeld T. Über die chronische Diplobacille conjunctivitis. Zentralbl Bakteriol. 1897;21:1–9.
24.
Zurück zum Zitat Shah SS, Ruth A, Coffin SE. Infection due to Moraxella osloensis: case report and review of the literature. Clin Infect Dis. 2000;30:179–81.CrossRefPubMed Shah SS, Ruth A, Coffin SE. Infection due to Moraxella osloensis: case report and review of the literature. Clin Infect Dis. 2000;30:179–81.CrossRefPubMed
25.
Zurück zum Zitat Dalmon C, Porco TC, Lietman TM, Prajna NV, Prajna L, Das MR, et al. The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci. 2012;53:1787–91.CrossRefPubMedPubMedCentral Dalmon C, Porco TC, Lietman TM, Prajna NV, Prajna L, Das MR, et al. The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci. 2012;53:1787–91.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Garg P, Mathur U, Athmanathan S, Rao GN. Treatment outcome of Moraxella keratitis: our experience with 18 cases: a retrospective review. Cornea. 1999;18:176–81.CrossRefPubMed Garg P, Mathur U, Athmanathan S, Rao GN. Treatment outcome of Moraxella keratitis: our experience with 18 cases: a retrospective review. Cornea. 1999;18:176–81.CrossRefPubMed
27.
Zurück zum Zitat Suzuki T, Ohashi Y. Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index. Cornea. 2013;32:e156–60.CrossRefPubMed Suzuki T, Ohashi Y. Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index. Cornea. 2013;32:e156–60.CrossRefPubMed
28.
29.
Zurück zum Zitat Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002;109:985–91.CrossRefPubMed Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002;109:985–91.CrossRefPubMed
30.
Zurück zum Zitat Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology. 2004;111:1495–503.CrossRefPubMed Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology. 2004;111:1495–503.CrossRefPubMed
31.
Zurück zum Zitat Yamamoto T. Bleb-related infection: clinical features and management. Taiwan J Ophthalmol. 2012;2:2–5.CrossRef Yamamoto T. Bleb-related infection: clinical features and management. Taiwan J Ophthalmol. 2012;2:2–5.CrossRef
32.
Zurück zum Zitat Hori N, Mochizuki K, Ishida K, Yamamoto T, Mikamo H. Clinical characteristics and risk factors of glaucoma filtering bleb infections. Nippon Ganka Gakkai Zasshi. 2009;113:951–63 (in Japanese).PubMed Hori N, Mochizuki K, Ishida K, Yamamoto T, Mikamo H. Clinical characteristics and risk factors of glaucoma filtering bleb infections. Nippon Ganka Gakkai Zasshi. 2009;113:951–63 (in Japanese).PubMed
33.
Zurück zum Zitat Nihonyanagi S, Wada T, Adachi Y, Fujimura H, Munekata S, Kanoh Y, et al. Trends in the occurrence and antibiotic susceptibility of Moraxella catarrhalis from 2009 to 2014. Jpn J Med Technol. 2016;65:268–74. Nihonyanagi S, Wada T, Adachi Y, Fujimura H, Munekata S, Kanoh Y, et al. Trends in the occurrence and antibiotic susceptibility of Moraxella catarrhalis from 2009 to 2014. Jpn J Med Technol. 2016;65:268–74.
34.
Zurück zum Zitat Stull TL, Stanford EJ. Pseudogonococcal ophthalmia neonatorum caused by Branhamella catarrhalis. Pediatr Infect Dis. 1986;5:104–5.CrossRefPubMed Stull TL, Stanford EJ. Pseudogonococcal ophthalmia neonatorum caused by Branhamella catarrhalis. Pediatr Infect Dis. 1986;5:104–5.CrossRefPubMed
35.
Zurück zum Zitat Maruyama Y, Shigemura T, Aoyama K, Nagano N, Nakazawa Y. Bacteremia due to Moraxella osloensis: a case report and literature review. Braz J Infect Dis. 2018;22:60–2.CrossRefPubMed Maruyama Y, Shigemura T, Aoyama K, Nagano N, Nakazawa Y. Bacteremia due to Moraxella osloensis: a case report and literature review. Braz J Infect Dis. 2018;22:60–2.CrossRefPubMed
36.
Zurück zum Zitat Hansen W, Butzler JP, Fuglesang JE, Henriksen SD. Isolation of penicillin and streptomycin resistant strains of Moraxella osloensis. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974;82:318–22.PubMed Hansen W, Butzler JP, Fuglesang JE, Henriksen SD. Isolation of penicillin and streptomycin resistant strains of Moraxella osloensis. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974;82:318–22.PubMed
Metadaten
Titel
Moraxella species: infectious microbes identified by use of time-of-flight mass spectrometry
verfasst von
Shunsuke Takahashi
Kazuhiro Murata
Kenji Ozawa
Hiroki Yamada
Hideaki Kawakami
Asami Nakayama
Yuko Asano
Kiyofumi Mochizuki
Hiroshige Mikamo
Publikationsdatum
04.07.2019
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 4/2019
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-019-00669-4

Weitere Artikel der Ausgabe 4/2019

Japanese Journal of Ophthalmology 4/2019 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.